Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-11

Clinical Trial Update: Dose Response Study of Nitisinone in Alkaptonuria [Phase 2]

View source ↗

Summary

A Phase 2 dose-response study evaluating nitisinone in alkaptonuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitisinone (Nitisinone)

Snippet

Sponsor: University of Liverpool | Conditions: Alkaptonuria | Phase 2 | Status: COMPLETED